Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pC0049-EF1a-dPSPCas13b-NES-HIV, H133A/H1058A Citations (2)

Originally described in: RNA editing with CRISPR-Cas13.
Cox DBT, Gootenberg JS, Abudayyeh OO, Franklin B, Kellner MJ, Joung J, Zhang F Science. 2017 Oct 25. pii: eaaq0180. doi: 10.1126/science.aaq0180. PubMed Journal

Articles Citing pC0049-EF1a-dPSPCas13b-NES-HIV, H133A/H1058A

Articles
Exosomes induce endolysosomal permeabilization as a gateway by which exosomal tau seeds escape into the cytosol. Polanco JC, Hand GR, Briner A, Li C, Gotz J. Acta Neuropathol. 2021 Feb;141(2):235-256. doi: 10.1007/s00401-020-02254-3. Epub 2021 Jan 8. PubMed
Pseudoknot-targeting Cas13b combats SARS-CoV-2 infection by suppressing viral replication. Yu D, Han HJ, Yu J, Kim J, Lee GH, Yang JH, Song BM, Tark D, Choi BS, Kang SM, Heo WD. Mol Ther. 2023 Jun 7;31(6):1675-1687. doi: 10.1016/j.ymthe.2023.03.018. Epub 2023 Mar 21. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.